obesity
PBAC accused of ‘lack of ambition’
Manufacturers of GLP-1 medications are stepping up pressure on the federal government to subsidise their products for weight loss Sponsors of glucagon-like peptide-1 (GLP-1) medications are accusing the Pharmaceutical Benefits Advisory Committee …
PBAC to advise on GLP-1s for obesity
Medicines advisory body notes “unmet clinical need for obesity treatments”, following deliberations on equitable access to GLP-1s The Pharmaceutical Benefits Advisory Committee (PBAC) will respond to the Minister for Health, Disability and …
Overweight, obesity and weight management
Obesity is a serious public health issue with widespread health, economic and social consequences. Tackling it requires a multifaceted approach, including public health policies, personal lifestyle changes, and, when necessary, …
A weighty issue
Overweight and obesity are a big problem in Australia. How can pharmacists help to tackle it and reduce the burden of disease? Sheshtyn Paola investigates KEY POINTS: Two in three …
Expert insights on the pharmacological management of overweight and obesity
This webinar aims to provide pharmacists with a comprehensive understanding of overweight and obesity, including its prevalence, health consequences, diagnosis and management. Gain expert knowledge from Professor John Dixon on …
World news wrapup: 1 March 2024
US cyber attack impacts pharmacies; NZ dispensing error saw loratadine laced with haloperidol; UK pharmacists burning out New Zealand: The Health and Disability Commissioner has found a pharmacy breached the …
Ozempic competitor to launch in spite of PBS knockback
Eli Lilly’s Mounjaro will be on the private scrip market by the end of September Revolutionary new type 2 diabetes drug Mounjaro – which is almost better known for producing …
Ozempic diabetes competitor gets PBS knockback
Eli Lilly’s Mounjaro would need “substantial price reduction”, says PBAC Mounjaro, the type-2 diabetes medication that the New York Times recently predicted “’could overshadow Ozempic” has been refused funding via …
Research Roundup
Debbie Rigby rounds up the latest in research news Electronic cigarettes and health outcomes An umbrella and systematic review of the global evidence has concluded that E‐cigarettes can be harmful …
Research Roundup
Debbie Rigby rounds up the latest in research news Vitamin D for the management of asthma This updated cochrane Review does not find evidence to support a role for vitamin …
Research Roundup
Debbie Rigby rounds up the latest in research news Management of motor and nonmotor symptoms in Parkinson disease Parkinson disease (PD) presents a challenging array of motor and nonmotor symptoms. …
Research Roundup
Debbie Rigby takes a look at the latest in research news Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum? Multiple therapeutic options for COVID-19 are …